159 related articles for article (PubMed ID: 29670818)
1. Fingolimod promotes blood-nerve barrier properties in vitro.
Nishihara H; Maeda T; Sano Y; Ueno M; Okamoto N; Takeshita Y; Shimizu F; Koga M; Kanda T
Brain Behav; 2018 Apr; 8(4):e00924. PubMed ID: 29670818
[TBL] [Abstract][Full Text] [Related]
2. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Nishihara H; Shimizu F; Sano Y; Takeshita Y; Maeda T; Abe M; Koga M; Kanda T
PLoS One; 2015; 10(3):e0121488. PubMed ID: 25774903
[TBL] [Abstract][Full Text] [Related]
3. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
Shimizu F; Sawai S; Sano Y; Beppu M; Misawa S; Nishihara H; Koga M; Kuwabara S; Kanda T
PLoS One; 2014; 9(8):e104205. PubMed ID: 25105500
[TBL] [Abstract][Full Text] [Related]
4. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
[TBL] [Abstract][Full Text] [Related]
5. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5.
Kashiwamura Y; Sano Y; Abe M; Shimizu F; Haruki H; Maeda T; Kawai M; Kanda T
Neurochem Res; 2011 May; 36(5):849-55. PubMed ID: 21293925
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate signaling at the blood-brain barrier.
Prager B; Spampinato SF; Ransohoff RM
Trends Mol Med; 2015 Jun; 21(6):354-63. PubMed ID: 25939882
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of human peripheral nerve microvascular endothelial cell lines: a new in vitro blood-nerve barrier (BNB) model.
Abe M; Sano Y; Maeda T; Shimizu F; Kashiwamura Y; Haruki H; Saito K; Tasaki A; Kawai M; Terasaki T; Kanda T
Cell Struct Funct; 2012; 37(2):89-100. PubMed ID: 22672995
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
[TBL] [Abstract][Full Text] [Related]
12. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.
Shimizu F; Sano Y; Saito K; Abe MA; Maeda T; Haruki H; Kanda T
Neurochem Res; 2012 Feb; 37(2):401-9. PubMed ID: 22002662
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral neuropathy and blood-nerve barrier].
Kanda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):959-62. PubMed ID: 20030260
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells.
Sano Y; Shimizu F; Nakayama H; Abe M; Maeda T; Ohtsuki S; Terasaki T; Obinata M; Ueda M; Takahashi R; Kanda T
Cell Struct Funct; 2007; 32(2):139-47. PubMed ID: 18057801
[TBL] [Abstract][Full Text] [Related]
15. The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.
Ubogu EE
J Vasc Res; 2013; 50(4):289-303. PubMed ID: 23839247
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
Chun J; Hartung HP
Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
[TBL] [Abstract][Full Text] [Related]
17. A novel method for measuring hydraulic conductivity at the human blood-nerve barrier in vitro.
Helton ES; Palladino S; Ubogu EE
Microvasc Res; 2017 Jan; 109():1-6. PubMed ID: 27592219
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
Blecharz KG; Haghikia A; Stasiolek M; Kruse N; Drenckhahn D; Gold R; Roewer N; Chan A; Förster CY
Mult Scler; 2010 Mar; 16(3):293-302. PubMed ID: 20203147
[TBL] [Abstract][Full Text] [Related]
19. GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways.
Dong C; Ubogu EE
Tissue Barriers; 2018; 6(4):1-22. PubMed ID: 30523753
[TBL] [Abstract][Full Text] [Related]
20. Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy.
Ben-Kraiem A; Sauer RS; Norwig C; Popp M; Bettenhausen AL; Atalla MS; Brack A; Blum R; Doppler K; Rittner HL
J Mol Med (Berl); 2021 Sep; 99(9):1237-1250. PubMed ID: 34018017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
